Australia will be able to vaccinate its entire 20 million population against bird flu within six months, drug manufacturer CSL Ltd. said on Wednesday, after successful completion of clinical trials. Developed with government backing, the new vaccine is the first to be registered in the Southern Hemisphere and could later be made available for supply and stockpile in Asia, CSL said. Full Story
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.
Australia’s CSL says bird flu vaccine test a success